...
首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis.
【24h】

Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis.

机译:抑制胶原蛋白受体盘基蛋白结构域受体1(DDR1)降低了肺癌骨转移中的细胞存活,归巢和定植。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We investigated the role of the collagen-binding receptor discoidin domain receptor-1 (DDR1) in the initiation and development of bone metastasis.We conducted immunohistochemical analyses in a cohort of 83 lung cancer specimens and examined phosphorylation status in a panel of human lung cancer cell lines. Adhesion, chemotaxis, invasiveness, metalloproteolytic, osteoclastogenic, and apoptotic assays were conducted in DDR1-silenced cells. In vivo, metastatic osseous homing and colonization were assessed in a murine model of metastasis.DDR1 was expressed in a panel of human lung cancer cell lines, and high DDR1 levels in human lung tumors were associated with poor survival. Knockdown (shDDR1) cells displayed unaltered growth kinetics in vitro and in vivo. In contrast, shDDR1 cells showed reduced invasiveness in collagen matrices and increased apoptosis in basal conditions and induced apoptosis in vitro. More importantly, conditioned media of DDR1-knockdown cells decreased osteoclastogenic activity in vitro. Consequently, in a model of tumor metastasis to bone, lack of DDR1 showed decreased metastatic activity associated with reduced tumor burden and osteolytic lesions. These effects were consistent with a substantial reduction in the number of cells reaching the bone compartment. Moreover, intratibial injection of shDDR1 cells significantly decreased bone tumor burden, suggesting impaired colonization ability that was highly dependent on the bone microenvironment.Disruption of DDR1 hampers tumor cell survival, leading to impaired early tumor-bone engagement during skeletal homing. Furthermore, inhibition of DDR1 crucially alters bone colonization. We suggest that DDR1 represents a novel therapeutic target involved in bone metastasis.
机译:我们研究了胶原结合受体Discoidin域受体1(DDR1)在骨转移的发生和发展中的作用。我们在83个肺癌样本中进行了免疫组织化学分析,并检查了一组人类肺癌中的磷酸化状态细胞系。在DDR1沉默的细胞中进行了粘附,趋化性,侵袭性,金属水解,破骨细胞和凋亡检测。在体内,在小鼠转移模型中评估了转移性骨的归巢和定植.DDR1在一组人类肺癌细胞系中表达,而DDR1在人类肺肿瘤中的高水平与生存期差有关。击倒(shDDR1)细胞在体外和体内均显示出不变的生长动力学。相反,shDDR1细胞在胶原蛋白基质中的侵袭性降低,在基础条件下细胞凋亡增加,并在体外诱导凋亡。更重要的是,DDR1-nockdown细胞的条件培养基在体外降低了破骨细胞的活性。因此,在肿瘤转移至骨的模型中,DDR1的缺乏显示出转移活性降低,与肿瘤负担减少和溶骨性病变相关。这些效果与到达骨腔的细胞数量的大量减少是一致的。此外,胫骨内注射shDDR1细胞显着降低了骨肿瘤负担,表明定植能力受损,高度依赖于骨微环境.DDR1的破坏阻碍了肿瘤细胞的存活,从而导致骨骼归巢过程中早期的肿瘤-骨骼参与受损。此外,DDR1的抑制会严重改变骨定植。我们建议DDR1代表参与骨转移的新型治疗靶点。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号